ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/26 | 1,545 | 1,568 | 1,505 | 1,526 | -33 | -2.1% | 388,800 |
2021/11/25 | 1,570 | 1,591 | 1,518 | 1,559 | -26 | -1.6% | 503,800 |
2021/11/24 | 1,541 | 1,592 | 1,532 | 1,585 | +60 | +3.9% | 722,600 |
2021/11/22 | 1,477 | 1,526 | 1,470 | 1,525 | +55 | +3.7% | 639,300 |
2021/11/19 | 1,500 | 1,527 | 1,456 | 1,470 | -32 | -2.1% | 1,028,600 |
2021/11/18 | 1,559 | 1,560 | 1,493 | 1,502 | -46 | -3% | 931,300 |
2021/11/17 | 1,650 | 1,650 | 1,539 | 1,548 | -91 | -5.6% | 1,032,900 |
2021/11/16 | 1,648 | 1,673 | 1,602 | 1,639 | -13 | -0.8% | 830,100 |
2021/11/15 | 1,635 | 1,660 | 1,591 | 1,652 | +35 | +2.2% | 656,300 |
2021/11/12 | 1,554 | 1,619 | 1,547 | 1,617 | +73 | +4.7% | 439,700 |
2021/11/11 | 1,536 | 1,552 | 1,525 | 1,544 | +8 | +0.5% | 280,000 |
2021/11/10 | 1,520 | 1,555 | 1,515 | 1,536 | +16 | +1.1% | 349,800 |
2021/11/09 | 1,566 | 1,574 | 1,515 | 1,520 | -56 | -3.6% | 663,600 |
2021/11/08 | 1,593 | 1,601 | 1,576 | 1,576 | -26 | -1.6% | 249,100 |
2021/11/05 | 1,618 | 1,618 | 1,577 | 1,602 | -9 | -0.6% | 345,000 |
2021/11/04 | 1,640 | 1,647 | 1,603 | 1,611 | -4 | -0.2% | 371,900 |
2021/11/02 | 1,622 | 1,637 | 1,612 | 1,615 | -7 | -0.4% | 260,900 |
2021/11/01 | 1,616 | 1,637 | 1,608 | 1,622 | +26 | +1.6% | 346,700 |
2021/10/29 | 1,606 | 1,609 | 1,575 | 1,596 | -5 | -0.3% | 313,000 |
2021/10/28 | 1,607 | 1,626 | 1,593 | 1,601 | -26 | -1.6% | 350,300 |
2021/10/27 | 1,641 | 1,651 | 1,623 | 1,627 | -10 | -0.6% | 344,000 |
2021/10/26 | 1,612 | 1,640 | 1,595 | 1,637 | +47 | +3% | 338,500 |
2021/10/25 | 1,601 | 1,619 | 1,570 | 1,590 | -35 | -2.2% | 512,400 |
2021/10/22 | 1,617 | 1,660 | 1,602 | 1,625 | +8 | +0.5% | 425,100 |
2021/10/21 | 1,682 | 1,689 | 1,617 | 1,617 | -97 | -5.7% | 617,200 |
2021/10/20 | 1,682 | 1,759 | 1,652 | 1,714 | +24 | +1.4% | 806,300 |
2021/10/19 | 1,715 | 1,738 | 1,674 | 1,690 | -30 | -1.7% | 504,500 |
2021/10/18 | 1,753 | 1,753 | 1,709 | 1,720 | -44 | -2.5% | 438,700 |
2021/10/15 | 1,718 | 1,764 | 1,700 | 1,764 | +66 | +3.9% | 673,000 |
2021/10/14 | 1,669 | 1,710 | 1,660 | 1,698 | +48 | +2.9% | 381,300 |
2021/10/13 | 1,695 | 1,702 | 1,640 | 1,650 | -49 | -2.9% | 451,400 |
2021/10/12 | 1,664 | 1,714 | 1,645 | 1,699 | +31 | +1.9% | 527,700 |
2021/10/11 | 1,627 | 1,668 | 1,606 | 1,668 | +55 | +3.4% | 399,900 |
2021/10/08 | 1,580 | 1,616 | 1,572 | 1,613 | +54 | +3.5% | 454,400 |
2021/10/07 | 1,556 | 1,588 | 1,546 | 1,559 | +6 | +0.4% | 503,300 |
2021/10/06 | 1,596 | 1,617 | 1,527 | 1,553 | -43 | -2.7% | 891,600 |
2021/10/05 | 1,601 | 1,639 | 1,579 | 1,596 | -45 | -2.7% | 808,500 |
2021/10/04 | 1,751 | 1,763 | 1,607 | 1,641 | -109 | -6.2% | 1,317,500 |
2021/10/01 | 1,636 | 1,798 | 1,628 | 1,750 | +106 | +6.4% | 1,682,100 |
2021/09/30 | 1,678 | 1,705 | 1,615 | 1,644 | +86 | +5.5% | 1,371,100 |
2021/09/29 | 1,521 | 1,562 | 1,514 | 1,558 | +5 | +0.3% | 376,100 |
2021/09/28 | 1,540 | 1,554 | 1,518 | 1,553 | +8 | +0.5% | 366,400 |
2021/09/27 | 1,555 | 1,560 | 1,527 | 1,545 | -7 | -0.5% | 307,400 |
2021/09/24 | 1,515 | 1,556 | 1,511 | 1,552 | +67 | +4.5% | 526,300 |
2021/09/22 | 1,499 | 1,522 | 1,483 | 1,485 | -15 | -1% | 610,100 |
2021/09/21 | 1,483 | 1,518 | 1,480 | 1,500 | -63 | -4% | 721,400 |
2021/09/17 | 1,536 | 1,563 | 1,507 | 1,563 | +24 | +1.6% | 617,000 |
2021/09/16 | 1,618 | 1,627 | 1,533 | 1,539 | -97 | -5.9% | 984,800 |
2021/09/15 | 1,670 | 1,679 | 1,620 | 1,636 | -44 | -2.6% | 449,200 |
2021/09/14 | 1,656 | 1,686 | 1,648 | 1,680 | +22 | +1.3% | 426,600 |
701~
750
件表示中 / 3553件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.21倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
科研薬 | 386,000円 | +22.8% | +113.0% | 4.92% | 10.29倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 316,000円 | +14.7% | -21.6% | 1.90% | 12.35倍 | 1.00倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム